Stockreport

Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis [Yahoo! Finance]

Organogenesis Holdings Inc. - Class A  (ORGO) 
Last organogenesis holdings inc. - class a earnings: 3/9 04:05 pm Check Earnings Report
PDF development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced the favorable [Read more]